EOM Pharmaceutical Holdings News

EOM Pharmaceutical Holdings Provides an Update on Its Lead Drug Candidate EOM613

MONTVALE, N.J., Nov. 7, 2023 /PRNewswire/ -- EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) ("EOM") today provides an update on its clinical program for its lead drug candidate EOM613. EOM613 is a pep

PR NewswireNov 7, 2023 07:00 ET

EOM Pharmaceutical Holdings Announces Topline Results of Its COVID-19 Clinical Trial of EOM613 in Brazil

Results indicate that EOM613 treatment mitigates cytokine release in patients with COVID-19 pulmonary vascular inflammation MONTVALE, N.J., Sept. 6, 2023 /PRNewswire/ -- EOM Pharmaceutical Holdings,

PR NewswireSep 6, 2023 07:00 ET

IPO Roundup: Richtech Robotics, Triller and More

Seeking AlphaAug 7, 2023 08:47 ET

EOM Pharmaceuticals Shelves Plans to Uplist Shares, Raise $15M

Seeking AlphaAug 3, 2023 18:01 ET

EOM PHARMACEUTICAL HOLDINGS, INC. ANNOUNCES NAME CHANGE FROM IMMUNOCELLULAR THERAPEUTICS, LTD.

Company to continue trading on the OTC Markets under the ticker symbol "IMUC" while pursuing listing on a national exchange MONTVALE, N.J., Nov. 10, 2022 /PRNewswire/ -- EOM Pharmaceutical Holdings,

PR NewswireNov 10, 2022 10:12 ET

EOM Pharmaceuticals files to uplist to Nasdaq

EOM Pharmaceuticals (OTCPK:IMUC) has filed to uplist from the Pink Sheets to the Nasdaq. As part of the application, EOM would trade on the Nasdaq under the ticker "EOM." EOM (formerly ImmunoCellular

Seeking AlphaJun 24, 2022 17:08 ET

Press Release: EOM Pharmaceuticals, Inc. And Immunocellular Therapeutics, Ltd. Announce Entry Into And Close Of Definitive Merger Agreement

EOM Pharmaceuticals, Inc. And Immunocellular Therapeutics, Ltd. Announce Entry Into And Close Of Definitive Merger Agreement Combined company will operate as EOM Pharmaceuticals Holdings, Inc.

Dow Jones NewswiresDec 2, 2021 08:10 ET

ImmunoCellular Therapeutics L, Inst Holders, 2Q 2019 (IMUC)

DJ ImmunoCellular Therapeutics L, Inst Holders, 2Q 2019 (IMUC) The following table shows the largest shareholders in IMMUNOCELLULAR THERAPEUTICS LTD CO (IMUC) for the quarter ended June 30, 20

Dow Jones NewswiresJul 22, 2019 03:59 ET

Press Release: ImmunoCellular Therapeutics Announces Asset Purchase Agreement with Private Biotechnology Company

Press Release: ImmunoCellular Therapeutics Announces Asset Purchase Agreement with Private Biotechnology Company ImmunoCellular Therapeutics Announces Asset Purchase Agreement with Private Biote

Dow Jones NewswiresJul 16, 2019 16:05 ET

ImmunoCellular Therapeutics L, Inst Holders, 1Q 2019 (IMUC)

DJ ImmunoCellular Therapeutics L, Inst Holders, 1Q 2019 (IMUC) The following table shows the largest shareholders in IMMUNOCELLULAR THERAPEUTICS LTD CO (IMUC) for the quarter ended March 31, 2

Dow Jones NewswiresApr 23, 2019 03:56 ET

DJ ImmunoCellular Therapeutics L, Inst Holders, 4Q 2018 (IMUC)

DJ ImmunoCellular Therapeutics L, Inst Holders, 4Q 2018 (IMUC) The following table shows the largest shareholders in IMMUNOCELLULAR THERAPEUTICS LTD CO (IMUC) for the quarter ended December 31

Dow Jones NewswiresJan 22, 2019 04:09 ET

DJ ImmunoCellular Therapeutics L, Inst Holders, 3Q 2018 (IMUC)

DJ ImmunoCellular Therapeutics L, Inst Holders, 3Q 2018 (IMUC) The following table shows the largest shareholders in IMMUNOCELLULAR THERAPEUTICS LTD CO (IMUC) for the quarter ended September 3

Dow Jones NewswiresOct 22, 2018 03:25 ET

DJ ImmunoCellular Therapeutics Ltd. (IMUC) Halted

DJ ImmunoCellular Therapeutics Ltd. (IMUC) Halted (END) Dow Jones Newswires October 16, 2018 12:28 ET (16:28 GMT) Copyright (c) 2018 Dow Jones & Company, Inc.

Dow Jones NewswiresOct 16, 2018 12:28 ET

DJ ImmunoCellular Files 8K - Director, Officer or Compensation Filing >IMUC

DJ ImmunoCellular Files 8K - Director, Officer or Compensation Filing >IMUC ImmunoCellular Therapeutics Ltd. (IMUC) filed a Form 8K - Director, Officer or Compensation Filing - with the U.S

Dow Jones NewswiresOct 15, 2018 16:35 ET

*DJ ImmunoCellular Therapeutics Announces Delisting and Deregistration of Common Stk and Listed Common Stk Warrants

Press Release: ImmunoCellular Therapeutics Announces Delisting and Deregistration of Common Stock and Listed Common Stock Warrants ImmunoCellular Therapeutics Announces Delisting and Deregistrat

Dow Jones NewswiresOct 15, 2018 16:09 ET